Brain/Spinal Cord Cancers
Radiation Therapy With or Without Temozolomide for Anaplastic Glioma (7880)
Phase III Trial On Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1P/19Q Deleted Anaplastic Glioma: The CATNON Intergroup Trial (RTOG 0834)
Investigator: George Laramore, MD, PhD; Conditions: Brain and Central Nervous System Tumors; Status: Recruiting; Study ID: NCT00626990
Phase III Study of Radiation Therapy With or Without Temozolomide For Symptomatic or Progressive Low-Grade Gliomas
Investigator: George Laramore, MD; Conditions: Brain and Central Nervous System Tumors, Neurotoxicity Syndromes; Status: Recruiting; Study ID: NCT00978458
PhaseII Study of MEDI-575 in Adult Subjects with Recurrent Glioblastoma Multiforme
Investigator: Marc Chamberlain, MD; Conditions: Glioblastoma Multiforme; Status: Closed; Study ID: NCT01268566
Phase II trial of bevacizumab (Avastin) in patients with recurrent or progressive meningiomas
Investigator: Marc Chamberlain, MD; Conditions: Brain Cancer; Status: Recruiting; Study ID: NCT01125046
A Phase II Study of Rindopepimut/GM-CSF in Patients with Relapsed EGFRvIII-Positive Glioblastoma
Investigator: Maciej Mrugala, MD, PhD; Conditions: Glioblastoma Multiforme; Status: Recruiting; Study ID: NCT01498328
Join Us On